Search
for
Sort by
Research 61–90 of 261
- JAK1 gain-of-function variant causes alopecia areata, atopic dermatitis, and autoimmune thyroid disease
- Complete responses and SALT zero scores in alopecia areata: not the same
- Novel Janus Kinase Inhibitors in the Treatment of Dermatologic Conditions
- A Novel Multimodal Approach in AAU Resistant to Conventional Therapies and Tofacitinib: A Case Report
- 75993 Safety of Janus kinase inhibitors for treatment of alopecia areata
- JAK-STAT pathway-associated skin diseases: a refined functional framework for inflammatory skin diseases
- The Role of JAK Inhibitors in Atopic Dermatitis, Alopecia Areata, and Vitiligo: A Review article
- Pharmacotherapy of alopecia areata
- JAK-Inhibitors Beyond the Label: Emerging Applications in Dermatology
- Evolving treatment paradigms in dermatology: Insights from emerging and repurposed therapies
- 93 Approach to Managing Recalcitrant Alopecia Areata With Combination Therapy: A Series of Five Cases in Black Pediatric Patients
- BH17 Bridging the gap: identifying dual-targeting therapies for patients with alopecia areata and coexisting immune-mediated inflammatory diseases
- Editor’s Picks June 2025
- Current options and treatment strategies for alopecia ateata in comorbidity with atopic diseases
- The Use of Janus Kinase Inhibitors for Primary Neutrophilic Cicatricial Alopecias
- Dual Relief: How Atopic Dermatitis Treatments Affect Alopecia Areata—A Small Retrospective Cohort Study
- Modern dermatology brings treatment even for alopecia areata
- P718 Observational real-world evidence on the efficacy and safety of Janus Kinase inhibitors (JAKi) in the treatment of moderate to severe Active Ulcerative Colitis (UC)
- Drug news and therapeutic news
- <i>JAMA Dermatology—</i>The Year in Review, 2021
- Approach to Managing Recalcitrant Alopecia Areata with Combination Therapy: A Series of Five Cases in Black Pediatric Patients
- Biologics and Small Molecule Targeted Therapies for Pediatric Alopecia Areata, Psoriasis, Atopic Dermatitis, and Hidradenitis Suppurativa in the US: A Narrative Review
- Editorial: Exploring innovative therapies for rare inflammatory skin diseases
- Turning JAK STATic, a peek into the future of dermatology therapeutics
- Cardiodermatology: the heart of the connection between the skin and cardiovascular disease
- Comparative Efficacy and Safety of Janus Kinase Inhibitors Used in Alopecia Areata: A Systematic Review and Meta-analysis
- New small molecules in dermatology: for the autoimmunity, inflammation and beyond
- Evolution of Ritlecitinib Population Pharmacokinetic Models During Clinical Drug Development
- Real-World Evidence for Baricitinib in the Treatment of Atopic Dermatitis and Alopecia Areata: Systematic Literature Review 2020–2023
- Combination Therapy with Baricitinib and Narrowband Ultraviolet B for Active Non-Segmental Vitiligo: A Retrospective Controlled Study